Interestingly, Woo et al. showed that PEMF treatment increased the chemotherapeutic drug doxorubicin’s effect on breast cancer G1-mediated cell cycle arrest and increased expression of G1/S pathway-related proteins like p53 [29]. The gene discussed is TP53; the disease is breast carcinoma.